BRIEF published on 02/03/2026 at 08:45, 3 months 7 days ago Poxel établit une ligne de crédit en fonds propres avec IRIS Capital Financement Poxel IRIS Capital Plan De Rétablissement Ligne De Crédit Sur Fonds Propres
BRIEF published on 02/03/2026 at 08:45, 3 months 7 days ago Poxel Establishes Equity Line with IRIS Capital Financing Recovery Plan Equity Line Poxel IRIS Capital
PRESS RELEASE published on 02/03/2026 at 08:40, 3 months 7 days ago Informations privilégiées / Autres communiqués Poxel annonce une nouvelle ligne de financement en fonds propres avec IRIS dans le cadre de son plan de continuation. Détails du financement et commentaires du Directeur général Financement Biopharmaceutique Plan De Continuation IRIS Poxel
PRESS RELEASE published on 02/03/2026 at 08:40, 3 months 7 days ago Inside Information / Other news releases Poxel announces implementation of equity line with IRIS Capital as part of recovery plan. New financing structure to enhance financial foundation Financial Structure Recovery Plan Equity Line Poxel IRIS Capital
BRIEF published on 01/30/2026 at 08:02, 3 months 11 days ago Commercial Court of Lyon Approves Poxel's Recovery Plan Financial Strategy Recovery Plan Commercial Court Poxel Debts Settlement
BRIEF published on 01/30/2026 at 08:02, 3 months 11 days ago Le tribunal de commerce de Lyon approuve le plan de redressement de Poxel Stratégie Financière Tribunal De Commerce Poxel Plan De Rétablissement Règlement Des Dettes
PRESS RELEASE published on 01/30/2026 at 07:57, 3 months 11 days ago Informations privilégiées / Autres communiqués Le Tribunal des activités économiques de Lyon valide le plan de continuation de POXEL SA, une société biopharmaceutique en phase clinique, mettant fin à la procédure de redressement judiciaire Plan De Continuation Redressement Judiciaire Validation Poxel SA Tribunal De Lyon
PRESS RELEASE published on 01/30/2026 at 07:57, 3 months 11 days ago Inside Information / Other news releases Poxel SA receives approval for recovery plan from Commercial Court of Lyon, closing reorganisation proceedings and focusing on business development, cost optimization, settlement of liabilities, and financial strengthening Business Development Recovery Plan Financial Restructuring Poxel SA Commercial Court Of Lyon
BRIEF published on 12/11/2025 at 19:47, 4 months 29 days ago Poxel publie les résultats de son assemblée générale et ses perspectives d'avenir Actionnaires Assemblée Générale Biopharmaceutique Poxel Plan De Rétablissement
BRIEF published on 12/11/2025 at 19:47, 4 months 29 days ago Résultats de l'Assemblée Générale de Poxel SA Actionnaires Plan De Redressement Société Biopharmaceutique Résultats Votes Assemblée Générale Poxel
Published on 05/09/2026 at 01:30, 1 day 10 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 12 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 11:45, 37 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 17 hours 17 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 15 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 17 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 17 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 17 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 17 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 17 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 17 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 17 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
